Introduction to Behavioral Neuroscience · Touch and Pain
Pain Relief
On this page 9 sections
In 30 seconds
Pain is not a fixed signal that travels unchanged from injury to brain — the nervous system can turn it up or down. This topic is about the machinery of pain relief: the brain's own descending control systems, the endogenous opioids Body-produced peptides (endorphins, enkephalins, dynorphins) that activate opioid receptors Full entry →, the gate that spinal circuits impose on incoming pain signals, and the psychological and behavioral factors (expectation, attention, stress, distraction) that modulate pain. It also covers how drugs relieve pain by acting on the receptors and channels that these systems use.
The key organizing idea: analgesia The reduction or absence of pain without loss of consciousness Full entry → (pain relief) is an active process. The brain does not just passively receive pain; it can suppress pain transmission at the spinal cord before the signal ever reaches conscious awareness. Endogenous opioids — endorphins, enkephalins, and dynorphins — are the body's own painkillers, released during stress, exercise, and sometimes even expectation of relief. Drugs like morphine work by mimicking these molecules at opioid receptors.
Why this matters
- Pain relief is a daily clinical and personal reality. From an athlete pushing through an injury to a patient recovering from surgery, understanding the mechanisms explains why relief is sometimes immediate, sometimes delayed, and sometimes absent.
- The placebo effect is real neurobiology, not "all in the head." Expectation of relief activates descending opioid systems; understanding this helps interpret clinical trials (where placebo groups often show measurable analgesia) and the design of pain studies.
- Opioid drugs are powerful and dangerous. Understanding that they act on the body's own receptors explains both their effectiveness and the risks of tolerance, dependence, and respiratory depression — a foundation for safe, cautious discussion of pain management.
- Non-drug relief makes sense mechanistically. Distraction, relaxation, counter-stimulation (like rubbing a bumped elbow or TENS units), and stress-induced analgesia Pain suppression during emergencies or intense stress Full entry → all engage the same descending and spinal circuits described here.
- Exam favorite. Expect questions on the descending pain pathway (periaqueductal gray → rostral ventromedial medulla → dorsal horn), the three endogenous opioid families, and how "rubbing it better" works.
The college version
Core Concepts
The gate: spinal circuits control what gets through
The dorsal horn of the spinal cord is not a passive relay. Incoming pain (C-fiber) signals excite projection neurons that carry pain upward, but they also contact inhibitory interneurons. The classic gate control theory Proposal that spinal circuits gate pain transmission, with touch input able to close the gate Full entry → (Melzack and Wall, 1965) proposed that activity in large-diameter touch fibers (A-beta) activates those inhibitory interneurons and "closes the gate" on pain transmission — which is why rubbing, shaking, or applying pressure near an injury reduces the pain. Modern accounts are more detailed, but the core idea survives: spinal inhibitory interneurons (many releasing GABA and glycine) can suppress pain transmission, and touch can recruit them. This is the mechanistic basis of counter-irritation, transcutaneous electrical nerve stimulation (TENS), and even "rubbing it better" after bumping your knee.
Descending control: the brain turns pain down at the source
The most important pain-relief circuit runs down from the brain to the spinal cord. The chain is:
- periaqueductal gray (PAG) Midbrain region whose stimulation produces profound analgesia Full entry → — a midbrain region that coordinates defensive and analgesic responses. Its neurons project to the next link.
- rostral ventromedial medulla (RVM) Medullary region relaying PAG output to the spinal cord Full entry → — receives PAG input and sends axons down the spinal cord in the dorsolateral funiculus.
- Dorsal horn — RVM axons release serotonin and enkephalins onto dorsal-horn interneurons and terminals, suppressing the transmission of incoming pain signals.
Stimulating the PAG produces profound analgesia in animals — so strong that surgery can be performed without conventional anesthetics. The PAG itself receives input from the amygdala and hypothalamus, which is how emotion and stress influence pain. This descending system is the neural substrate for stress-induced analgesia: an injured soldier or athlete may not feel pain until the immediate emergency passes.
Endogenous opioids: the body's own painkillers
Three families of endogenous opioid peptides are commonly taught:
- Endorphins (especially beta-endorphin) — released from the pituitary and hypothalamus, prominent in stress-induced analgesia and exercise-related "runner's high."
- Enkephalins — short peptides found widely in the spinal cord and brain, including the inhibitory interneurons of the dorsal horn.
- Dynorphins — larger peptides whose roles are more complex, sometimes producing analgesia and sometimes modulating other effects.
They act at opioid receptors — mu, delta, and kappa — which are G-protein-coupled receptors that (when activated) reduce neurotransmitter release and hyperpolarize neurons, damping pain transmission at several sites: in the dorsal horn (blocking incoming pain signals), in the PAG and RVM (boosting descending inhibition), and in the thalamus/brainstem (blunting the perception and emotional impact of pain). Morphine and other opioid drugs are agonists at these receptors, especially mu — which explains both their potent analgesia and their side effects (constipation, sedation, respiratory depression, and the risk of dependence).
Expectation, attention, and the placebo response
Pain experience is modifiable by cognitive factors:
- placebo analgesia Pain relief from expectation of relief, mediated by endogenous opioids Full entry → — when a person expects relief (from a sugar pill, an injection, or a reassuring clinician), endogenous opioid systems are measurably engaged; the effect is partly blocked by naloxone An opioid receptor antagonist that blocks opioid effects Full entry →, an opioid antagonist. Expectation genuinely changes spinal pain processing.
- Attention and distraction — focusing on a task, a video game, or a conversation reduces perceived pain; pain demands attention, and competing tasks reduce the resources available to it.
- Fear and anxiety amplify pain — the same descending pathways that suppress pain can, under other conditions (via the RVM's "facilitatory" neurons), enhance it. This bidirectional control explains why context so strongly shapes pain.
Drug strategies by mechanism
A mechanistic overview (educational, not prescribing advice): local anesthetics block sodium channels on nociceptive fibers, stopping signals at the source; NSAIDs (aspirin, ibuprofen) inhibit prostaglandin synthesis, reducing the inflammatory sensitization that makes nociceptors hyper-responsive; and opioid analgesics activate mu receptors in the pain network. The takeaway for study purposes is that different drugs target different links in the chain — transduction, transmission, and modulation — which is why they combine and why their side-effect profiles differ. Dosing, indications, and contraindications are clinical decisions and are not covered here.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Analgesia and anesthesia | Both reduce sensation | Analgesia blocks pain specifically; anesthesia blocks all sensation (and general anesthesia also produces unconsciousness) |
| Endorphins and endorphins-as-drugs | "The body's own morphine" | Endorphins are peptides your body makes; morphine is a plant-derived drug that mimics them at the same receptors |
| Gate control theory and descending control | Two ways the spinal cord is controlled | Gate control is local spinal circuitry (touch closes the gate); descending control is a brain-to-spinal pathway that actively inhibits transmission |
| Placebo and "fake" relief | Placebo as imaginary | Placebo analgesia is a measurable, naloxone-blockable engagement of the endogenous opioid system |
| Opioid receptors and opioid drugs | Receptor vs. drug | Receptors are proteins the body uses for its own peptides; drugs are external agonists that activate them — with different potency, selectivity, and side effects |
| Stress-induced analgesia and "ignoring" pain | Willpower vs. physiology | Stress-induced analgesia is a hardwired opioid response, not a matter of simply choosing not to feel pain |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your brain is like a security guard who can turn down the volume on pain. When you bump your knee, rubbing it sends a "touch" message that tells the spinal cord to quiet the pain message. Your body even makes its own painkiller chemicals (like endorphins) that lock onto special "pain-off" switches — and some medicines, like morphine, work by using those same switches.
Worked example
Consider a soccer player who injures her ankle during a championship match. She keeps playing for several minutes, barely limping — stress-induced analgesia (endogenous opioids released during intense arousal and physical exertion) is suppressing her pain. That evening the ankle swells and hurts badly: the emergency is over, descending inhibition has relaxed, and inflammatory sensitization has set in. She rubs the ankle and applies gentle pressure — counter-stimulation — which recruits touch-driven spinal inhibition and gives temporary relief.
Later, she takes an NSAID, which reduces prostaglandin-mediated sensitization of the nociceptors themselves, and the ache fades over the following days as the inflammatory response subsides. If she had a severe injury requiring stronger relief, an opioid analgesic would engage mu receptors throughout the pain network — effective, but with side effects and dependence risk that require careful clinical judgment.
Now add the placebo wrinkle: in a study, the same player is given a cream described as "a proven pain reliever" and reports significantly less pain — even when the cream is inert. The relief is real, and it is mediated by her own endogenous opioid system (giving naloxone removes much of it). This is why double-blind, placebo-controlled trials exist: expectation itself is a treatment, and it must be measured before a drug's true effect can be isolated.
Key takeaways
- The gate concept: touch (A-beta) input recruits spinal inhibitory interneurons that suppress pain transmission — the basis of rubbing, TENS, and counter-stimulation.
- Descending analgesia chain: PAG → RVM → dorsal horn (serotonin + enkephalins) — the brain can actively suppress pain at the spinal cord.
- Three endogenous opioid families: endorphins, enkephalins, dynorphins; three receptor classes: mu, delta, kappa.
- Opioid drugs are mu-receptor agonists — potent analgesia plus sedation, constipation, respiratory depression, tolerance, and dependence risk.
- Placebo analgesia is opioid-mediated — expectation engages real descending inhibition (blocked by naloxone).
- Stress-induced analgesia explains why injuries during emergencies may not hurt until later.
- Descending control is bidirectional — facilitatory RVM neurons can amplify pain under anxiety, explaining why context matters.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
Trace the descending analgesia pathway from the midbrain to the spinal cord, naming the structures and transmitters.
Show answer
Periaqueductal gray (PAG) projects to the rostral ventromedial medulla (RVM), which sends axons down the dorsolateral funiculus to the dorsal horn, where serotonin and enkephalins suppress pain transmission.
Why does rubbing a bumped elbow reduce the pain, according to gate-control logic?
Show answer
Rubbing activates large-diameter touch (A-beta) fibers that excite spinal inhibitory interneurons, which suppress the pain-transmitting neurons — "closing the gate" on the pain signal.
Name the three endogenous opioid families and the three major opioid receptor G-protein-coupled receptor (mu, delta, kappa) that dampens pain signaling when activated Full entry → classes.
Show answer
Families: endorphins, enkephalins, dynorphins. Receptors: mu, delta, kappa.
How do we know placebo analgesia is opioid-mediated?
Show answer
Giving naloxone (an opioid antagonist) largely blocks placebo analgesia, showing the effect depends on endogenous opioid signaling rather than imagination alone.
Why does morphine relieve pain but also cause constipation, sedation, and respiratory depression?
Show answer
Mu receptors are distributed beyond pain pathways — in the gut (constipation), brainstem respiratory centers (slowed breathing), and reward circuits (dependence risk) — so activating them affects those systems too.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- analgesia
- The reduction or absence of pain without loss of consciousness
- gate control theory
- Proposal that spinal circuits gate pain transmission, with touch input able to close the gate
- periaqueductal gray (PAG)
- Midbrain region whose stimulation produces profound analgesia
- rostral ventromedial medulla (RVM)
- Medullary region relaying PAG output to the spinal cord
- endogenous opioids
- Body-produced peptides (endorphins, enkephalins, dynorphins) that activate opioid receptors
- opioid receptor
- G-protein-coupled receptor (mu, delta, kappa) that dampens pain signaling when activated
- placebo analgesia
- Pain relief from expectation of relief, mediated by endogenous opioids
- stress-induced analgesia
- Pain suppression during emergencies or intense stress
- naloxone
- An opioid receptor antagonist that blocks opioid effects
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.